The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.50
Bid: 60.00
Ask: 65.00
Change: -0.50 (-0.79%)
Spread: 5.00 (8.333%)
Open: 63.00
High: 63.00
Low: 62.50
Prev. Close: 63.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Dev Clever to cancel shares; Tintra raises funds

Fri, 16th Dec 2022 21:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Asimilar Group PLC - capital market company - Notes an announcement made by Dev Clever Holdings PLC regarding its decision to submit a request to the Financial Conduct Authority for the cancellation of the listing of its ordinary shares. It holds a 8.5% stake in Dev Clever's issued share capital.

----------

Dev Clever Holdings PLC - software developer for immersive learning and career guidance - Plans to submit a request to cancel its shares, as it thinks that it is unlikely that it will attract the necessary material investment from investors to execute its growth strategy "in these current market conditions." "The board is of the view that, right now, the considerable cost, management time and the legal and regulatory obligations associated with maintaining a listing are materially disproportionate to the benefits to the company. It also believes there is currently reduced investment 'appetite' for smaller UK listed companies and pre-profit technology companies generally and particularly those where significant capital for growth is required and that it would be easier to access private market finance," the company states.

----------

APQ Global Ltd - Guernsey-based emerging markets investor - Unaudited book value per Ordinary Share as at November 30 stands at 11.68 US cents.

----------

SkinBioTherapeutics PLC- Skin health-focused life sciences company - Raises gross proceeds of GBP2.5 million through the placing of 15.6 million new ordinary shares at a placing price of 16 pence. The price represents a 7.2 % to the closing middle market price of 17.25 pence per Ordinary Share on Wednesday. The placing shares will represent 10% of the company's issued ordinary share capital prior to the placing.

----------

Tintra PLC - Windsor, Berkshire-based firm building banking and infrastructure technology systems - Completes the placement to institutional investor Fintech Leaders Fund LLC for USD10.0 million. Plan to use the proceeds to fund the continuing development of the company's artificial intelligence platform and regulatory licensing build, as well as for general working capital purposes. "This support from Fintech Leaders Fund is another validation of the strength of our mission especially with a team that shares our vision of revolutionising how emerging markets directly benefit from financial inclusion. Not least by their alignment of thinking on the importance of robust ESG goals supported by the work of The Tintra Foundation and of Tintra plc as we drive financial inclusion into emerging markets," CEO Richard Shearer says.

----------

Kodal Minerals PLC - mineral exploration and development company focused on lithium and gold assets in West Africa - Says it is progressing with plant engineering and environmental studies required for the dense media separation at its Bougouni lithium project in southern Mali. Adds that it is finalising engineering and environmental work to support formal approval for the DMS option from the Mali government.

----------

NetScientific PLC - life sciences and sustainability technology investment firm - Reports that its portfolio company, PDS Biotechnology Corp completed its enrolment in the first stage of the checkpoint inhibitor refractory group of its Versatile-002 phase 2 study. "We are delighted with PDS Biotech's continued progress in its clinical trials, including the Phase 2 trial for combined therapy with Merck's Keytruda drug as detailed in their announcement. Congratulations to Frank and his team with their company's continued advancements," CEO Ilian Iliev comments.

----------

Infrastructure India PLC - invests in infrastructure assets in India's energy and transport sectors - Expects to report a net liability position for the year that ended March 31, 2022. This was based on agreed preliminary terms with a third party and the ascribed net minimum consideration for itss largest holding, Distribution Logistics Infrastructure, it explains. Says that the proposed transaction is structured in a deferred, performance-based, and contingent consideration.

----------

Sareum Holdings PLC - Cambridge, England-based biotechnology company focused on developing kinase inhibitors for autoimmune disease & cancer - Records "good progress" in its financial year that ended June 30. Remains confident in its future despite some recent setbacks. Believes that it has a strong pipeline of kinase inhibitors with the potential to provide great benefit to patients. Says that it is committed to advancing SDC-1801 into clinical development and is focused on finding the quickest and clearest pathway to obtaining authorisation for clinical studies.

----------

Mast Energy Developments PLC - London-based developer of reserve power generations plants - Says that the remaining deferred consideration for Pyebridge site has been waived. Plans to pay GBP2.5 million for the Pyebridge site, after GBP400,000 of consideration waved. "We are very pleased with the settlement agreement negotiated that resulted in a direct cash saving to MED of c. £400k which is in fact an additional amount of cash available to the Company, and the positive effect thereof on the Site's economics, profitability, and investment return. We look forward to providing the market with further updates in due course as we progress," CEO Pieter Krügel says.

----------

Chamberlin PLC - West Midlands-based castings and engineering company - Says that its Scunthorpe-based foundry Russell Ductile Casting recorded revenue exceeding GBP1 million for the first time in November. Adds that it has a "strong" sales enquiry pipeline of around GBO17 million. Says that the investment in a new plant and equipment at Russell is now completed.

----------

Kavango Resources PLC - London-based mineral explorer focused on Botswana - Says that its drilling programme at the Kronos copper target zone was extended. Says that the drill programme will to continue to the Christmas break and restart in new year. Says that cores and rock chip samples are currently being logged and interpreted to assess "potential vectors" indicating the proximity of a potential mineralising system.

----------

Beacon Energy PLC - Isle of Man, UK-based oil and gas company - Enters into conditional sale and purchase agreement with Tulip Oil and Deutsche Rohstoff for Rhein Petroleum GmbH. The sellers will receive new ordinary shares in Beacon Energy that will equal a 33%. Says that the transaction constitute a reverse takeover. Appoints interim CEO Larry Bottomley as permanent CEO, effective immediately.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
15 Apr 2024 11:06

NetScientific investee secures funding to develop product range

(Alliance News) - NetScientific PLC on Monday said its portfolio company ProAxsis Ltd secured GBP1.8 million in investment.

Read more
27 Mar 2024 18:47

TRADING UPDATES: Empire Metals targets key milestones in Australia

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Mar 2024 17:04

NetScientific "significantly" advances strategic goals

(Alliance News) - NetScientific PLC on Wednesday released a portfolio and strategy update.

Read more
23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
1 Dec 2023 11:59

IN BRIEF: NetScientific investee DeepTech Recycling bags GBP1 million

NetScientific PLC - technology and life sciences investor - Portfolio company DeepTech Recycling Ltd closes GBP1 million fundraising. DeepTech, in which NetScientific holds a 30% stake, is a company focused on chemical recycling of plastic waste. Last December, it bought the assets of Recycling Technologies Ltd out of administration. The fundraise is carried out via an advance share subscription agreement and is the first closing of a target investment programme of around GBP3 million, with further investment anticipated within the next six months.

Read more
9 Nov 2023 19:41

IN BRIEF: NetScientific's portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor -

Read more
6 Nov 2023 12:00

IN BRIEF: NetScientific says Ventive on fire with new investment

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor - Says portfolio company Ventive, a London-based designer and manufacturer of heating and ventillation solutions, has successfuly closed a new investment of around GBP900,000. Funding included GBP316,000 from existing shareholders and the conversion of two existing convertible loans valued at about GBP600,000. Investment is part of Ventive's proposed GBP1 million to GBP1.5 million programme, with further investments expected by April 30. NetScientific now holds an 11% total equity stake in Ventive, with a post-investment fair value of GBP893,000 - up from GBP52,000 at December 31.

Read more
23 Oct 2023 21:10

NetScientific investee claims promising results in biomarker study

(Alliance News) - NetScientific PLC on Monday said its investee PDS Biotechnology Corp was "encouraged" by study data for its PDS0101 combined with Merck & Co Inc's drug Keytruda.

Read more
3 Oct 2023 17:12

IN BRIEF: NetScientific portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investment company - Reports that its portfolio company, PDS Biotechnology Corp, has announced updated interim data from the Versatile-002 phase two clinical trial evaluating PDS0101 in combination with Merck & Co Inc's Keytruda in patients with unresectable, recurrent, or metastatic HPV16-positive head and neck squamous cell carcinoma.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
13 Sep 2023 21:32

NetScientific's Q-Bot completes GBP3.5 million investment programme

(Alliance News) - NetScientific PLC on Wednesday said that its portfolio company, Q-Bot, has successfully closed a GBP3.5 million investment programme.

Read more
14 Aug 2023 19:49

IN BRIEF: NetScientific's PDS suffers wider loss as R&D costs mount

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Portfolio company PDS Biotechnology Corp reports results for the quarter to June 30. Net loss was USD11.5 million, widened from USD5.8 million the year before. Higher loss primarily due to costs incurred in connection with research and development programmes, which more than doubled to USD8.0 million from USD3.8 million. Loss per share of USD0.37 compared to USD0.20 before. Further, PDS reports the successful submission of final clinical protocol and supporting information to the US Food & Drug Administration to initiate phase 3 Versatile-003 trial in the fourth quarter. Adds biomarker data from Versatile-002 will be presented at the European Society for Medical Oncology Congress.

Read more
30 Jun 2023 14:07

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Jun 2023 14:11

TRADING UPDATES: tinyBuild bemoans disappointing interim performance

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2023 17:15

IN BRIEF: NetScientific investee Vortex nabs six-figure investment

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Announces completion of new GBP3.2 million investment round in portfolio company Vortex Biotech Holdings Ltd, led by EMV Capital. NetScientific converted its GBP400,000 loan into equity alongside new Vortex investors. NetScientific now has a 24.98% total equity holding in Vortex. This equates to a post-investment fair value of GBP2.8 million, quadruple the GBP700,000 value reported at December 31.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.